期刊文献+

人补体受体1型SCR1-3功能域基因的克隆表达及生物活性鉴定 被引量:2

Cloning,expression of the SCR1-3 domains of human complement receptor type 1 and analysis of its activities
下载PDF
导出
摘要 目的实现人补体受体1型功能域SCR1-3基因的克隆、表达及生物学活性鉴定。方法从人外周血中提取总RNA,通过逆转录获得cDNA,PCR扩增获得编码CR1-SCR1-3基因序列;克隆到毕赤酵母分泌表达质粒pPIC9K,构建重组质粒pPIC9K-CR1-SCR1-3,菌落PCR、双酶切鉴定后测序;线性化重组质粒电转化毕赤酵母KM71基因组中,经菌落PCR技术筛选在G418平板上生长的多拷贝阳性转化子;摇瓶发酵和甲醇诱导,SDS-PAGE和Western-blot鉴定目的蛋白表达;镍柱亲和层析纯化目的蛋白;用体外抑制补体溶血反应实验测定目的蛋白的生物活性。结果获得了人CR1-SCR1-3编码区序列,测序结果与与GenBank中的相应序列一致;SDS-PAGE和Western-blot表明目的基因在毕赤酵母中实现了分泌表达;体外实验证实经纯化后的CR1-SCR1-3能够明显抑制补体溶血。结论成功构建重组表达质粒pPIC9K-CR1-SCR1-3,在毕赤酵母中实现了CR1-SCR1-3的分泌表达,该蛋白具有较高的抑制补体生物活性。 We aim to clone and express the first three short consensus repeat modules of human complement receptor type 1 in Pichia pastoris,and characterize its bioactivities.Firstly,the total RNA was prepared from human peripheral blood,and the gene fragment of CR1-SCR1-3 was amplified by RT-PCR,then the fragment was cloned into Pichia pastoris secretory expression vector pPIC9K to construct pPIC9K-CR1-SCR1-3.After identification by colony PCR,restriction enzyme digestion and DNA sequence,the linearized plasmid was electrotransported into the Pichia pastoris.Positive clones were selected at different concentration of G418 in plates of yeast extract peptone Dextrose medium(YPD) and identified by colony direct PCR.Then positive recombinants were fermented in shake flask induced by methanol.SDS-PAGE and Western-Blot indicated that the target protein was secreted in the supernatant of culture medium.NI-NTA agarose metal-chelate-affinity chromatography was used for protein purification.Then SRBC haemolytic assay in vitro demonstrated that the purified protein could inhibit complement hemolysis in vitro.All the results show that the recombinant plasmid pPIC9K-CR1-SCR1-3 is successfully constructed,and the CR1-SCR1-3 protein could be highly expressed in the Pichia pastoris,which is proved to possess well complement control activity.
出处 《免疫学杂志》 CAS CSCD 北大核心 2012年第1期64-68,共5页 Immunological Journal
基金 国家自然科学基金(30471723) 重庆市自然科学基金(2007BB5011)
关键词 人补体受体1型 毕赤酵母 分泌表达 补体抑制活性 CR1 Pichia pastoris Secretory expression Complement control activity
  • 相关文献

参考文献14

  • 1Arumugam TV, Magnus T, Woodruff TM, et at. Complement mediators in ischemia-reperfusion injury[J]. Clin Chim Acta, 2006, 374 (1): 33-45.
  • 2Damman J, Hoeger S, Boneschansker L, et at. Targeting complement activation in brain-dead donors improves renal function after transplantation[J]. Transpl Immunol, 2011, 24 (4): 233-237.
  • 3Wagner E, Frank MM. Therapeutic potential of complement modulation[J]. Nat Rev Drug Discov, 2010, 9 (1): 43-56.
  • 4Liu D, Niu ZX. The structure, genetic polymorphisms, expression and biological functions of complement receptor type 1 (CR1/CD35) [J]. Immunopharmacol Immunotoxico], 2009, 31 (4): 524-535.
  • 5Furtado PB, Huang CY, Ihyembe D, et al. The partly folded back solution structure arrangement of the 30 SCR domains in human complement receptor type 1 (CR1) permits access to its C3b and C4b ligands [J]. J Mol Biol, 2008, 375 (1): 102-118.
  • 6谭兵,张德纯,汪正清.重组人可溶性补体受体1型SCR15-18片段表达纯化及生物活性鉴定[J].第三军医大学学报,2007,29(10):892-895. 被引量:6
  • 7谭兵,兰阳军,张德纯,汪正清.重组人可溶性补体受体1型SCR15-18片段对心肌缺血再灌注损伤的保护作用[J].中华心血管病杂志,2007,35(11):1037-1040. 被引量:11
  • 8何莉,杨永涛,郭光金,刘高科,汪正清.sCR1-SCR15-18蛋白减轻补体介导的大鼠脑缺血/再灌注损伤[J].中国病理生理杂志,2009,25(12):2436-2440. 被引量:4
  • 9Holers VM. The spectrum of complement alternative pathway-mediated diseases[J], Immunol Rev, 2008, 223 (1): 300-316.
  • 10Busche MN, Walsh MC, McMullen ME, et al Mannose-binding lectin plays a critical role in myocardial ischaemia and reperfusion injury in a mouse model of diabetes [J]. Diabetologia, 2008, 51 (8): 1544-1551.

二级参考文献44

共引文献15

同被引文献14

  • 1Arumugam T V, Magnus T, Woodruff T M, et al. Complement media- tors in ischemia-reperfusion injury [ J ]. Clin Chim Acta, 2006, 374 (1/2) : 33 -45.
  • 2Saver J L. Improving reperfusion therapy for acute ischaemic stroke [J]. J Thromb Haemost, 2011, 9(Suppl 1 ) : 333 -343.
  • 3Li S, Xian J, He L, et al. The protective effect of SCR(15-18) on cerebral ischemia-reperfusion injury [ J ]. Neurol Res, 2011, 33 ( 8 ) : 866 - 874.
  • 4Costa C, Zhao L, Shen Y, et al. Role of complement component C5 in cerebral ischemia/reperfusion injury[ J]. Brain Res, 2006, 1100( 1 ) : 142 - 151.
  • 5Ducruet A F, Zacharia B E, Hickman Z L, et al. The complement cascade as a therapeutic target in intracerebral hemorrhage [ J ]. Exp Neurol, 2009, 219(2): 398-403.
  • 6Hill J H, Ward P A. The phlogistic role of C3 leu kotactic fragments in myocardial infarcts ofrats[J]. J Exp Med, 1971, 133(4) : 885 - 900.
  • 7Komotar R J, Starke R M, Arias E J, et al. The complement cas- cade: new avenues in stroke therapy [ J 1- Curt Vasc Pharmacol, 2009, 7(3) : 287 - 292.
  • 8Furtado P B, Huang C Y, Ihyembe D, et al. The partly folded back solution structure arrangement of the 30 SCR domains in human com- plemertt receptor type 1 (CR1) permits access to its C3h and C4h lig- ands[J]. J Mol Biol, 2008, 375(1) : 102 -118.
  • 9Liu D, Niu Z X. The structure, genetic polymorphisms, expression and biological functions of complement receptor type 1 ( CR1/CD35 ) [J]. Immunopharmaeol Immunotoxicol, 2009, 31 (4): 524-535.
  • 10谭兵,兰阳军,张德纯,汪正清.重组人可溶性补体受体1型SCR15-18片段对心肌缺血再灌注损伤的保护作用[J].中华心血管病杂志,2007,35(11):1037-1040. 被引量:11

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部